These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34784549)

  • 1. Structural study of the recognition mechanism of tau antibody Tau2r3 with the key sequence (VQIINK) in tau aggregation.
    Tsuchida T; Susa K; Kibiki T; Tsuchiya T; Miyamoto K; In Y; Minoura K; Taniguchi T; Ishida T; Tomoo K
    Biochem Biophys Res Commun; 2021 Dec; 585():36-41. PubMed ID: 34784549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the human tau PHF core domain VQIINK complexed with the Fab domain of monoclonal antibody Tau2r3.
    Tsuchida T; Susa K; Kibiki T; Tsuchiya T; Miyamoto K; In Y; Minoura K; Taniguchi T; Ishida T; Tomoo K
    FEBS Lett; 2020 Apr; ():. PubMed ID: 32282060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray structure of the PHF core C-terminus: insight into the folding of the intrinsically disordered protein tau in Alzheimer's disease.
    Sevcik J; Skrabana R; Dvorsky R; Csokova N; Iqbal K; Novak M
    FEBS Lett; 2007 Dec; 581(30):5872-8. PubMed ID: 18061582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8.
    Malia TJ; Teplyakov A; Ernst R; Wu SJ; Lacy ER; Liu X; Vandermeeren M; Mercken M; Luo J; Sweet RW; Gilliland GL
    Proteins; 2016 Apr; 84(4):427-34. PubMed ID: 26800003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based inhibitors of tau aggregation.
    Seidler PM; Boyer DR; Rodriguez JA; Sawaya MR; Cascio D; Murray K; Gonen T; Eisenberg DS
    Nat Chem; 2018 Feb; 10(2):170-176. PubMed ID: 29359764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau Antibody Structure Reveals a Molecular Switch Defining a Pathological Conformation of the Tau Protein.
    Chukwu JE; Pedersen JT; Pedersen LØ; Volbracht C; Sigurdsson EM; Kong XP
    Sci Rep; 2018 Apr; 8(1):6209. PubMed ID: 29670132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation.
    Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X
    ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Structure Biology of Tau and Clue for Aggregation Inhibitor Design.
    Wang D; Huang X; Yan L; Zhou L; Yan C; Wu J; Su Z; Huang Y
    Protein J; 2021 Oct; 40(5):656-668. PubMed ID: 34401998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Basis for Recognition of a Unique Epitope by a Human Anti-tau Antibody.
    Zhang H; Zhu X; Pascual G; Wadia JS; Keogh E; Hoozemans JJ; Siregar B; Inganäs H; Stoop EJM; Goudsmit J; Apetri A; Koudstaal W; Wilson IA
    Structure; 2018 Dec; 26(12):1626-1634.e4. PubMed ID: 30318466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization and preliminary X-ray diffraction analysis of tau protein microtubule-binding motifs in complex with Tau5 and DC25 antibody Fab fragments.
    Cehlar O; Skrabana R; Kovac A; Kovacech B; Novak M
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Oct; 68(Pt 10):1181-5. PubMed ID: 23027743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological Changes of Tau Related to Alzheimer's Disease.
    Chu D; Liu F
    ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau protein liquid-liquid phase separation can initiate tau aggregation.
    Wegmann S; Eftekharzadeh B; Tepper K; Zoltowska KM; Bennett RE; Dujardin S; Laskowski PR; MacKenzie D; Kamath T; Commins C; Vanderburg C; Roe AD; Fan Z; Molliex AM; Hernandez-Vega A; Muller D; Hyman AA; Mandelkow E; Taylor JP; Hyman BT
    EMBO J; 2018 Apr; 37(7):. PubMed ID: 29472250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
    Combs B; Hamel C; Kanaan NM
    Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization.
    Dominguez-Meijide A; Vasili E; König A; Cima-Omori MS; Ibáñez de Opakua A; Leonov A; Ryazanov S; Zweckstetter M; Griesinger C; Outeiro TF
    Sci Rep; 2020 Jul; 10(1):12827. PubMed ID: 32732936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth arrest specific protein 7 inhibits tau fibrillogenesis.
    Shimizu T; Hirose K; Uchida C; Uchida T
    Biochem Biophys Res Commun; 2020 May; 526(2):281-286. PubMed ID: 32216967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A soluble oligomer of tau associated with fiber formation analyzed by NMR.
    Peterson DW; Zhou H; Dahlquist FW; Lew J
    Biochemistry; 2008 Jul; 47(28):7393-404. PubMed ID: 18558718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zn
    Li X; Du X; Ni J
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradation.
    Esteves-Villanueva JO; Trzeciakiewicz H; Loeffler DA; Martić S
    Biochemistry; 2015 Jan; 54(2):293-302. PubMed ID: 25545358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation regulates fibrillation of an aggregation core peptide in the second repeat of microtubule-binding domain of human tau.
    Inoue M; Kaida S; Nakano S; Annoni C; Nakata E; Konno T; Morii T
    Bioorg Med Chem; 2014 Nov; 22(22):6471-80. PubMed ID: 25440728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of serine 305 in tau inhibits aggregation.
    Strang KH; Sorrentino ZA; Riffe CJ; Gorion KM; Vijayaraghavan N; Golde TE; Giasson BI
    Neurosci Lett; 2019 Jan; 692():187-192. PubMed ID: 30423399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.